The Company would like to clarify that the Notification Letter has no current effect on the listing or trading of the Company's securities on Nasdaq. Pursuant to Rule 5810 (c) (3) (A) of the Nasdaq ...

CHARLOTTE, N.C., June 10, 2025 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced it will be added to the broad-market Russell 3000 ® Index following the annual reconstitution of the ...

Having previously identified a panel of candidate mRNA biomarkers with potential clinical relevance, Mainz Biomed will now begin the verification process in collaboration with Crown Bioscience, a ...